IGC Pharma (IGC) Raw Materials (2019 - 2026)

IGC Pharma (IGC) has 8 years of Raw Materials data on file, last reported at $447000.0 in Q1 2026.

• Raw Materials for Q1 2026 came in at $447000.0, down 59.51% year-over-year; the trailing twelve-month figure through Mar 2026 was $447000.0 (down 59.51% YoY), and the FY2026 annual result was $447000.0, down 59.51% from the prior year.
• Raw Materials was little changed at $447000.0 in Q1 2026 per IGC's latest filing, from $446000.0 in the prior quarter.
• Over five years, Raw Materials peaked at $3.0 million in Q4 2022 and troughed at $446000.0 in Q3 2025.
• A 5-year average of $1.5 million and a median of $1.1 million in 2024 frame the typical range for Raw Materials.
• The sharpest annual moves came in 2022 and 2025: Raw Materials surged 30.5% in 2022, then plunged 59.6% in 2025.
• A 5-year view of Raw Materials shows it stood at $3.0 million in 2022, then tumbled by 53.52% to $1.4 million in 2023, then fell by 24.4% to $1.1 million in 2024, then tumbled by 58.28% to $446000.0 in 2025, then rose by 0.22% to $447000.0 in 2026.
• Business Quant data shows IGC's Raw Materials at $447000.0 in Q1 2026, $446000.0 in Q4 2025, and $446000.0 in Q3 2025.